Trinity Biotech plc (TRIB)
NASDAQ: TRIB · Real-Time Price · USD
0.9600
-0.0370 (-3.71%)
At close: Dec 5, 2025, 4:00 PM EST
0.9800
+0.0200 (2.08%)
After-hours: Dec 5, 2025, 4:31 PM EST
Trinity Biotech Market Cap
Trinity Biotech has a market cap or net worth of $17.82 million as of December 5, 2025. Its market cap has increased by 42.65% in one year.
Market Cap
17.82M
Enterprise Value
113.42M
1-Year Change
42.65%
Ranking
Category
Stock Price
$0.96
Market Cap Chart
Since October 9, 1997, Trinity Biotech's market cap has decreased from $44.82M to $17.82M, a decrease of -60.23%. That is a compound annual growth rate of -3.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 17.82M | 16.20% |
| Dec 31, 2024 | 15.34M | -6.42% |
| Dec 29, 2023 | 16.39M | -56.55% |
| Dec 30, 2022 | 37.73M | 26.22% |
| Dec 31, 2021 | 29.89M | -62.47% |
| Dec 31, 2020 | 79.64M | 268.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |